Literature DB >> 11704885

CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.

T Fischer-Smith1, S Croul, A E Sverstiuk, C Capini, D L'Heureux, E G Régulier, M W Richardson, S Amini, S Morgello, K Khalili, J Rappaport.   

Abstract

Increases in circulating CD14+/CD16+ monocytes have been associated with HIV dementia; trafficking of these cells into the CNS has been proposed to play an important role in the pathogenesis of HIV-induced neurological disorders. This model suggests that events outside the CNS leading to monocyte activation initiate the process leading to HIV dementia. To investigate the role of this activated monocyte subset in the pathogenesis of HIV dementia, we examined brain specimens from patients with HIV encephalopathy (HIVE), HIV without encephalopathy, and seronegative controls. An accumulation of perivascular macrophages was observed in HIVE. The majority of these cells identified in microglial nodules and in the perivascular infiltrate were CD14+/CD16+. P24 antigen colocalized with both CD14 and CD16 suggesting that the CD14+/CD16+ macrophage is a major reservoir of HIV-1 infection in CNS. Using CD45/LCA staining, the perivascular macrophage was distinguished from resident microglia. In addition to perivascular and nodular localizations, CD16 also stained ramified cells throughout the white matter. These cells were more ramified and abundant than cells positive for CD14 in white matter. Double staining for p24 and CD16 suggests that these cells were often infected with HIV-1. The prominent distribution of CD14+ cells in HIVE prompted our analysis of soluble CD14 levels in cerebrospinal fluid. Higher levels of soluble CD14 (sCD14) were observed in patients with moderate-to-severe HIV dementia, suggesting the utility of sCD14 as a surrogate marker. CD14+/CD16+ monocytes may play a role in other neurological disorders and sCD14 may be useful for evaluating these conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704885     DOI: 10.1080/135502801753248114

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  50 in total

Review 1.  Pathology of HIV-1 infection of the central nervous system. A review.

Authors:  L R Sharer
Journal:  J Neuropathol Exp Neurol       Date:  1992-01       Impact factor: 3.685

2.  Bone marrow derived elements and resident microglia in brain inflammation.

Authors:  H Lassmann; M Schmied; K Vass; W F Hickey
Journal:  Glia       Date:  1993-01       Impact factor: 7.452

3.  Mechanisms of leukocyte trafficking into the CNS.

Authors:  D T Wu; S E Woodman; J M Weiss; C M McManus; T G D'Aversa; J Hesselgesser; E O Major; A Nath; J W Berman
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

4.  Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events.

Authors:  E Lien; P Aukrust; A Sundan; F Müller; S S Frøland; T Espevik
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

Review 5.  Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.

Authors:  M S Meltzer; D R Skillman; P J Gomatos; D C Kalter; H E Gendelman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

6.  Unique monocyte subset in patients with AIDS dementia.

Authors:  L Pulliam; R Gascon; M Stubblebine; D McGuire; M S McGrath
Journal:  Lancet       Date:  1997-03-08       Impact factor: 79.321

Review 7.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

8.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia.

Authors:  E H Aylward; P D Brettschneider; J C McArthur; G J Harris; T E Schlaepfer; J D Henderer; P E Barta; A Y Tien; G D Pearlson
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

10.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  187 in total

1.  Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

Authors:  Suad Kapetanovic; Erin Leister; Sharon Nichols; Tracie Miller; Katherine Tassiopoulos; Rohan Hazra; Harris A Gelbard; Kathleen M Malee; Betsy Kammerer; Armando J Mendez; Paige L Williams
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 2.  Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility.

Authors:  Megan K Patrick; James B Johnston; Christopher Power
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy.

Authors:  Tracy Fischer-Smith; Sidney Croul; Aderonke Adeniyi; Katarzyna Rybicka; Susan Morgello; Kamel Khalili; Jay Rappaport
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 4.  HIV reservoirs and strategies for eradication.

Authors:  Miranda Z Smith; Fiona Wightman; Sharon R Lewin
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

5.  Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease.

Authors:  Jay Rappaport; Joseph R Berger
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

6.  The immunosuppressive domain of the transmembrane envelope protein gp41 of HIV-1 binds to human monocytes and B cells.

Authors:  Michael Mühle; Tobias Kroniger; Kerstin Hoffmann; Joachim Denner
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

7.  Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.

Authors:  Kenneth Williams; Susan Westmoreland; Jane Greco; Eva Ratai; Margaret Lentz; Woong-Ki Kim; Robert A Fuller; John P Kim; Patrick Autissier; Prahbat K Sehgal; Raymond F Schinazi; Norbert Bischofberger; Michael Piatak; Jeffrey D Lifson; Eliezer Masliah; R Gilberto González
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

8.  Imiquimod and interferon-alpha augment monocyte-mediated astrocyte secretion of MCP-1, IL-6 and IP-10 in a human co-culture system.

Authors:  Michael D Rizzo; Robert B Crawford; Anthony Bach; Sera Sermet; Andrea Amalfitano; Norbert E Kaminski
Journal:  J Neuroimmunol       Date:  2019-05-20       Impact factor: 3.478

9.  Systemic immune system alterations in early stages of Alzheimer's disease.

Authors:  Rongzhen Zhang; Robert G Miller; Catherine Madison; Xia Jin; Ronald Honrada; Will Harris; Jonathan Katz; Dallas A Forshew; Michael S McGrath
Journal:  J Neuroimmunol       Date:  2013-02-04       Impact factor: 3.478

Review 10.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.